There are many conflicting views about how to get the Covid-19 pandemic under control in the U.S. Our study in the Journal of Public Health, published in July 2020, explains how experts can use existing datasets and analytical tools to evaluate the risks of different policies, and determine the resources and policies needed to save lives during this pandemic and any future pandemics
Read More »Author: Caroline Bradford
NCHR joins Nonprofits in asking FDA to only allow Covid vaccine distribution after phase 3 trials completed
August 10, 2020. Experts urge that COVID-19 vaccines are made widely available only after the Food and Drug Administration (FDA) has been able to evaluate safety and efficacy data from completed Phase 3 clinical trials.
Read More »The Number Of Women Having Their Breast Implants Removed Is On The Rise
Women’s Health, August 8, 2020. A growing number of women, especially athletes, are having their breast implants removed to alleviate symptoms of breast implant illness.
Read More »Public health experts want rigorous FDA review of Covid vaccine data
Politico, August 7, 2020. A letter to FDA Commissioner Stephen Hahn argues that FDA should allow the distribution of a future coronavirus vaccine only after evaluating safety and effectiveness data from completed Phase 3 trials.
Read More »NCHR joins Nonprofits in criticizing White House blocking CDC from sharing Covid-19 data
July 23, 2020. Nonprofit coalition asks Sec. Azar to rescind guidance to stop reporting coronavirus data to CDC and send it only to HHS.
Read More »